AG˹ٷ

STOCK TITAN

[Form 4] OraSure Technologies Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

OraSure Technologies, Inc. (OSUR) � Form 4 insider filing: On 24 June 2025, director John P. Kenny received 6,657 shares of common stock under the company’s Stock Award Plan in lieu of cash fees. The award vested immediately at a reference price of $3.0082 per share. Following the grant, Kenny’s direct ownership increased to 147,204 shares. No derivative securities were reported and no shares were sold.

OraSure Technologies, Inc. (OSUR) � Comunicazione interna Form 4: Il 24 giugno 2025, il direttore John P. Kenny ha ricevuto 6.657 azioni ordinarie nell'ambito del Piano di Assegnazione Azionaria della società in sostituzione dei compensi in contanti. L'assegnazione è stata immediatamente maturata a un prezzo di riferimento di 3,0082 $ per azione. Dopo la concessione, la proprietà diretta di Kenny è aumentata a 147.204 azioni. Non sono stati segnalati titoli derivati né sono state vendute azioni.

OraSure Technologies, Inc. (OSUR) � Presentación interna Formulario 4: El 24 de junio de 2025, el director John P. Kenny recibió 6.657 acciones ordinarias bajo el Plan de Premios de Acciones de la empresa en lugar de honorarios en efectivo. La concesión se otorgó inmediatamente a un precio de referencia de $3.0082 por acción. Tras la asignación, la propiedad directa de Kenny aumentó a 147.204 acciones. No se reportaron valores derivados ni se vendieron acciones.

OraSure Technologies, Inc. (OSUR) � 내부� 보고� Form 4: 2025� 6� 24�, 이사 John P. Kenny� 현금 수수� 대� 회사� 주식 보상 계획� 따라 6,657� 보통�� 받았습니�. � 보상은 주당 $3.0082� 기준 가격으� 즉시 확정되었습니�. 보상 � Kenny� 직접 소유 주식은 147,204�� 증가했습니다. 파생 증권은 보고되지 않았으며 주식� 매도되지 않았습니�.

OraSure Technologies, Inc. (OSUR) � Déclaration d’initié Formulaire 4 : Le 24 juin 2025, le directeur John P. Kenny a reçu 6 657 actions ordinaires dans le cadre du Plan d’attribution d’actions de la société en lieu et place des honoraires en espèces. L’attribution a été immédiatement acquise à un prix de référence de 3,0082 $ par action. Après cette attribution, la détention directe de Kenny est passée à 147 204 actions. Aucun titre dérivé n’a été déclaré et aucune action n’a été vendue.

OraSure Technologies, Inc. (OSUR) � Insider-Meldung Form 4: Am 24. Juni 2025 erhielt Direktor John P. Kenny im Rahmen des Aktienprämienplans des Unternehmens 6.657 Stammaktien anstelle von Barvergütungen. Die Zuteilung wurde sofort zu einem Referenzpreis von 3,0082 $ pro Aktie wirksam. Nach der Zuteilung erhöhte sich Kennys Direktbesitz auf 147.204 Aktien. Es wurden keine Derivate gemeldet und keine Aktien verkauft.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider stock grant; signals alignment but immaterial to valuation.

The filing shows a routine fee-in-stock election rather than an open-market purchase. While additional ownership can marginally align director incentives with shareholders, the $20 k value (6,657&Բ;×&Բ;$3.0082) is negligible relative to OraSure’s market capitalization and floating share count. No change in control, strategy, or liquidity is implied, so market impact should be minimal.

OraSure Technologies, Inc. (OSUR) � Comunicazione interna Form 4: Il 24 giugno 2025, il direttore John P. Kenny ha ricevuto 6.657 azioni ordinarie nell'ambito del Piano di Assegnazione Azionaria della società in sostituzione dei compensi in contanti. L'assegnazione è stata immediatamente maturata a un prezzo di riferimento di 3,0082 $ per azione. Dopo la concessione, la proprietà diretta di Kenny è aumentata a 147.204 azioni. Non sono stati segnalati titoli derivati né sono state vendute azioni.

OraSure Technologies, Inc. (OSUR) � Presentación interna Formulario 4: El 24 de junio de 2025, el director John P. Kenny recibió 6.657 acciones ordinarias bajo el Plan de Premios de Acciones de la empresa en lugar de honorarios en efectivo. La concesión se otorgó inmediatamente a un precio de referencia de $3.0082 por acción. Tras la asignación, la propiedad directa de Kenny aumentó a 147.204 acciones. No se reportaron valores derivados ni se vendieron acciones.

OraSure Technologies, Inc. (OSUR) � 내부� 보고� Form 4: 2025� 6� 24�, 이사 John P. Kenny� 현금 수수� 대� 회사� 주식 보상 계획� 따라 6,657� 보통�� 받았습니�. � 보상은 주당 $3.0082� 기준 가격으� 즉시 확정되었습니�. 보상 � Kenny� 직접 소유 주식은 147,204�� 증가했습니다. 파생 증권은 보고되지 않았으며 주식� 매도되지 않았습니�.

OraSure Technologies, Inc. (OSUR) � Déclaration d’initié Formulaire 4 : Le 24 juin 2025, le directeur John P. Kenny a reçu 6 657 actions ordinaires dans le cadre du Plan d’attribution d’actions de la société en lieu et place des honoraires en espèces. L’attribution a été immédiatement acquise à un prix de référence de 3,0082 $ par action. Après cette attribution, la détention directe de Kenny est passée à 147 204 actions. Aucun titre dérivé n’a été déclaré et aucune action n’a été vendue.

OraSure Technologies, Inc. (OSUR) � Insider-Meldung Form 4: Am 24. Juni 2025 erhielt Direktor John P. Kenny im Rahmen des Aktienprämienplans des Unternehmens 6.657 Stammaktien anstelle von Barvergütungen. Die Zuteilung wurde sofort zu einem Referenzpreis von 3,0082 $ pro Aktie wirksam. Nach der Zuteilung erhöhte sich Kennys Direktbesitz auf 147.204 Aktien. Es wurden keine Derivate gemeldet und keine Aktien verkauft.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kenny John P.

(Last) (First) (Middle)
C/O ORASURE TECHNOLOGIES, INC.
220 EAST FIRST STREET

(Street)
BETHLEHEM PA 18015

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC [ OSUR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/24/2025 A 6,657(1) A $3.0082 147,204 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan in lieu of cash fees with immediate vesting.
/s/ Michele Anthony, Attorney-in-Fact 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many OraSure (OSUR) shares did director John P. Kenny acquire?

He received 6,657 shares of common stock.

What was the transaction date for the OSUR insider grant?

The grant was dated June 24, 2025 and reported on June 25, 2025.

At what price were the restricted shares valued?

The shares were valued at $3.0082 each under the Stock Award Plan.

What is John P. Kenny’s total direct ownership after the grant?

He now directly owns 147,204 OSUR shares.

Did the insider sell any shares or exercise options?

No. The filing reports only an acquisition of restricted stock; no sales or option exercises occurred.
Orasure Tech

NASDAQ:OSUR

OSUR Rankings

OSUR Latest News

OSUR Stock Data

228.89M
71.04M
4.07%
91.51%
3.28%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
United States
BETHLEHEM